MENU
CHRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Coherus Oncology (CHRS) Ownership - Who owns Coherus Oncology?
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
333 Twin Dolphin Drive
Phone
+1 650 649-3530
Employees
306
Web
https://www.coherus.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
96.22M
P/E Ratio
1.89
Total Cash
125.99M
Projected Growth
N/A
Total Debt
269.9M
Revenue
266.96M
Risk (Beta)
1.07
Dividend Yield
N/A
Total Cash/Share
1.09
Total Debt/Equity
N/A
Revenue/Share
2.35 USD as % of share price
Fundamentals
CHRS
Capitalization
96.2M
P/E Ratio
1.89
Risk (Beta)
1.07
Dividend Yield
N/A
Total Cash
126M
Total Cash/Share
1.09
Total Debt
270M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.35%
Revenue
267M
ROE
N/A
Book Value
-131.99M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
1.21
Current Revenue Per Employee
237473.69
Dividends Per Share - Security
N/A
EBITDA
60.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
37.47
Revenue To Assets
5.29
Shares Held By Institutions
119M
Shares Outstanding - Current
116M
Total Liabilities
581M
Total Volume MTD
N/A
Value
-1
Gain YTD
-42.094
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a maker of biologic therapeutics for oncology and inflammatory diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
333 Twin Dolphin Drive
Phone
+1 650 649-3530
Employees
306
Web
https://www.coherus.com